Talis Biomedical (TLIS) Competitors

Astrotech (NASDAQ:ASTC) and Talis Biomedical (NASDAQ:TLIS) are both small-cap aerospace companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, community ranking, institutional ownership, valuation, risk, analyst recommendations and earnings.

Does the MarketBeat Community favor ASTC or TLIS?

Astrotech received 119 more outperform votes than Talis Biomedical when rated by MarketBeat users. Likewise, 56.64% of users gave Astrotech an outperform vote while only 37.50% of users gave Talis Biomedical an outperform vote.

Company	Underperform	Outperform
Astrotech	Outperform Votes 128 56.64%	Underperform Votes 98 43.36%
Talis Biomedical	Outperform Votes 9 37.50%	Underperform Votes 15 62.50%

Do institutionals & insiders believe in ASTC or TLIS?

24.4% of Astrotech shares are held by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are held by institutional investors. 14.9% of Astrotech shares are held by company insiders. Comparatively, 46.0% of Talis Biomedical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Does the media favor ASTC or TLIS?

In the previous week, Astrotech had 1 more articles in the media than Talis Biomedical. MarketBeat recorded 1 mentions for Astrotech and 0 mentions for Talis Biomedical. Astrotech's average media sentiment score of 1.52 beat Talis Biomedical's score of 0.00 indicating that Astrotech is being referred to more favorably in the media.

Company	Overall Sentiment
Astrotech	Very Positive
Talis Biomedical	Neutral

Which has stronger valuation & earnings, ASTC or TLIS?

Astrotech has higher revenue and earnings than Talis Biomedical. Astrotech is trading at a lower price-to-earnings ratio than Talis Biomedical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrotech	$419K	24.59	-$11.67M	-$8.17	-0.74
Talis Biomedical	$300K	9.72	-$62.01M	-$28.02	-0.06

Is ASTC or TLIS more profitable?

Talis Biomedical has a net margin of 0.00% compared to Astrotech's net margin of -3,198.09%. Astrotech's return on equity of -40.44% beat Talis Biomedical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrotech	-3,198.09%	-40.44%	-37.41%
Talis Biomedical	N/A	-79.74%	-57.16%

Which has more volatility and risk, ASTC or TLIS?

Astrotech has a beta of 0.33, meaning that its stock price is 67% less volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

Summary

Astrotech beats Talis Biomedical on 10 of the 15 factors compared between the two stocks.